Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - DEPRECIATION & AMORTIZATION
Depreciation & Amortization HALO - Halozyme Therapeutics, Inc.
84.9 M
LAST VALUE
432.11%
2 YEAR CAGR
104.23%
5 YEAR CAGR
52.75%
10 YEAR CAGR